Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05628181 · ClinicalTrials.gov registry record · NA
A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD)
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT05628181 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 129 participants.
The verdict
NCT05628181, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The goal of this project is to address central nervous system-active polypharmacy (CNS polyRx) in people living with dementia (PLWD) through focus groups and an educational intervention. The project included three interconnected aims and engaged PLWD, care partners (CP), and clinicians. Aim 1 consisted of focus group discussions with PLWD and CPs, conducted to inform the development of the educational intervention. This aim was not considered a clinical trial. Therefore, this registration covers Aims 2 and 3, which constitute the clinical trial components. These included mailing the educational "nudge" intervention to PLWD and conducting qualitative interviews with clinicians. No care partners were involved in Aims 2 and 3. The study hypothesizes that the total standardized daily dosage (TSDD) of medication classes contributing to CNS polyRx will decrease from baseline to 4 months among participants receiving the intervention.
Interventions
- BEHAVIORAL Educational nudge intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2024-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05628181
The ClinicalTrials.gov registry entry for NCT05628181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational nudge intervention is the first listed.
NCT05628181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05628181 about?
NCT05628181 is a clinical study titled "A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD)". The goal of this project is to address central nervous system-active polypharmacy (CNS polyRx) in people living with dementia (PLWD) through focus groups and an educational intervention. The project included three interconnected aims and engaged PLWD, care partners (CP), and clinicians. Aim 1 consi...
What is the current status of trial NCT05628181?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2023-05-08. Estimated completion is 2024-08-19.
What interventions are being tested in trial NCT05628181?
The interventions under investigation include: Educational nudge intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05628181?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.